Prescription Drug Monitoring Programs

Prescription Drug Monitoring Programs (PDMP/PMPs) are critical decision support tools that state officials, health care professionals, and law enforcement officers use to address opioid and prescription drug abuse and diversion. PDMP/PMPs electronically collect, analyze and disclose specified information about prescribed controlled substances and other monitored substances dispensed to patients and their representatives.

Search for any of NAMSDL’s PDMP/PMP materials

Document Selector

 

 

Type of Document
Sub-Topic of Document

 

Source of Document

Results

 

January 2019
The 2019 National Drug Control Strategy from the Office of National Drug Control Policy (ONDCP) that establishes the national initiatives and priorities to combat illicit drug use and treat people suffering from substance use disorders.
January 2019
Map of frequency of data reporting authorized by bill/statute/rule/ordinance (exceptions for veterinarians or others may apply; effective dates may vary). Preparation for implementation may result in a time difference between the enactment or effective date and the date of implementation of the reporting frequency.
January 2019
Map of the prescriber PDMP/PMP mandatory use laws by state
November 2017
Map of interjurisdictional sharing of prescription drug monitoring program (PDMP/PMP) data. State/Local Jurisdictions Legally Authorized to Share Their PMP Data with Other State/Local Jurisdictions or Users Located in other State/Local Jurisdictions (47 States, D.C. and St. Louis County, Missouri)
September 2017
This issue of NAMSDL Case Law Update focuses on seven cases related to the access to and use of prescription monitoring program (“PMP”) records. The issues addressed in these decisions involve: (1) the preemption of state law by the administrative subpoena provisions of the Controlled Substances Act (“CSA”) (21 U.S.C. § 876); (2) privacy rights implicated by accessing PMP records; and (3) whether or not certain login information constitutes protected PMP information. The cases discussed in this issue originate from California, Louisiana, Mississippi, Oregon, Utah, and Virginia. Cases are divided by type of court (federal or state) and then listed in approximate descending order of appellate level.
September 2017
Prescription Drug Monitoring Programs (PDMPs): Critical Decision Support Tools to Respond to the Opioid Crisis Congressional Briefing Final Agenda and Presentation
July 2017
Map of established and operational prescription drug monitoring programs (PDMPs/PMPs), includes 51 Jurisdictions (49 States, D.C. and St. Louis County)
June 2017
2017 mid-year highlights of Prescription Drug Monitoring Program (PDMP/PMP) bills
June 2017
50 state compilation and highlights of key state requirements of mandated use of state Prescription Drug Monitoring Programs (PDMPs/PMPs)
June 2017
50 state compilations table of prescription drug monitoring program (PDMP/PMP) data retention timelines

 

Notice of Federal Funding Disclaimer

 This website is funded in part through a cooperative agreement from the Bureau of Justice Assistance, Office of Justice Programs, U.S. Department of Justice and a grant from the Office of National Drug Control Policy. No federal instrumentality, including the Office of Drug Control Policy, the U.S. Department of Justice or its components, operate, control, are responsible for or necessarily endorse this website (including, without limitation, its content, technical infrastructure, policies and any services or tools provided).